STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...
Researchers from University of California San Diego School of Medicine have found that testing for lipoprotein(a)—a genetic ...
GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights over traditional panel testing. The company achieved a significant turnaround, becoming cash flow ...
The bipartisan legislation, introduced this week in the House and Senate, seeks to prevent more cuts to Medicare reimbursement rates for diagnostic tests.
More than four years after the COVID-19 pandemic caused the world to come to a standstill, lessons in pandemic response are still being learned. What we know: the global pandemic disproportionately ...
Rebecca Munoz said biomarker testing made a huge impact on her cancer journey. Now she's advocating for others to get the same option. "It was life-changing, obviously, to say the least," Munoz said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback